Study on the preparation of a compound based on five traditional Chinese medicines and its in vivo hypoglycenic activity

• Authors: Jianping Yong , Shaoji Lu , Jianchen Cheng , Ruiwen Huang
• Languages of publication: EN

Abstracts

EN

In this work, we obtained the water extracts of Dendrobium officinale Kimura et Migo, Astragalus membranaceus (Fisch.) Bunge, the leaves of Morus alba L., Pueraria lobata (Willd.) Ohwi, Panax notoginseng (Burk) F. H. Chen. Respectively. Then, we made a compound with these water extracts of Dendrobium officinale Kimura et Migo (13.33 %), Astragalus membranaceus (Fisch.) Bunge (29.17 %), the leaves of Morus alba L. (12.5 %), Pueraria lobata (Willd.) Ohwi (20.83 %), Panax notoginseng (Burk) F. H. Chen (6.95 %), accessory materials (17.22 %). Subsequently, we tested its in vivo hypoglycenic activity, and the results showed that this compound can reduce the blood sugar of the model mouse without toxicity.

Keywords

EN

Astragalus membranaceus (Fisch.) Bunge; Dendrobium officinale Kimura et Migo; Panax notoginseng (Burk) F. H. Chen; Pueraria lobata (Willd.) Ohwi; compound; hypoglycenic activity; the leaves of Morus alba L.; water extract

Discipline

• MEDICINE: MEDICINE

• Publisher: Scientific Publishing House „DARWIN”
• Journal: World News of Natural Sciences
• Year: 2024
• Volume: 54
• Pages: 1-8

Contributors

author

Jianping Yong

• Xiamen Institute of Rare-earth Materials, Chinese Academy of Sciences, Xiamen, Fujian, China

author

Shaoji Lu

• Xiamen Tasman Bio-Tech Research Institute, Xiamen, Fujian, China

author

Jianchen Cheng

• Xiamen Tasman Bio-Tech Research Institute, Xiamen, Fujian, China

author

Ruiwen Huang

• Xiamen Tasman Bio-Tech Research Institute, Xiamen, Fujian, China

References

• [1] Blaslov K, Naranda F S, Kruljac I, et al. Treatment approach to type 2 diabetes: past, present, and future. World J Diabetes 9(12) (2018) 209-219
• [2] Aynalen S B, Zeleke A J. Prevalence of diabetes mellitus and its risk factors among individuals aged 15 years and above in Mizan-Aman Town, Southwest Ethiopia, 2016: a Cross-Sectional Study. Int J Endocrinol. 2018 (2018) 9317987
• [3] Sun H， Saeedi P， Karuranga S, et al . IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 138 (2018) 271-281
• [4] Jiang F J R, Yong J P, Lu S J, et al. The Progress on the Chemical Constituents and Biological Activities of Dendrobium Officinalis Caulis. Current Traditional Medicine. (2024) DOI:10.2174/0122150838254907230920054721
• [5] Zuo J X, Dai X, He W, et al. Research progress on liver-protective active components and mechanism of action of Dendrobii Officinalis Caulis. Chinese Traditional and Herbal Drugs. 55(4) (2024) 1365-1376
• [6] Zhou M, Liao X, Li L L, et al. Preparation process and immune activity of Dendrobium officinale Kimura et Migo fermentation liquid. Food Science and Technology. 49(1) (2024) 94-102
• [7] Huang X J, Wang Z Q, Nie S P. Functional activity research and industrialization status of Dendrobium officinale. Journal of Chinese Institute of Food Science and Technology. 23(11) (2023) 1-12
• [8] Xi J Y, Su Y J, Zhao K P, et al. Research progress in medicinal and food homologous of Astragali Radix. West China Journal of Pharmaceutical Sciences. 38(6) (2023) 718-724.
• [9] Peng T, Zhang H, Yang Y F, et al. Research progress on pharmacological mechanism of astragalus in the treatment of vascular dementia. China Medicine. 19(2) (2024) 297-302
• [10] Sun J H, Zhou Y, Sun Y E, et al. Research progress on bioactive components of Astragalus membranaceus and their application in food. China Food Additives. 34(12) (2023) 272-276
• [11] XI J Y, Su Y D, Zhao K P, et al. Research progress in medicinal and food homologous of Astragali Radix. West China Journal of Pharmaceutical Sciences. 38(6) (2023) 718-724
• [12] Chen A R, Wang J Y, Hua J, et al. Theoretical discussion on treatment of diabetic cardiomyopathy by Astragali Radix-Puerariae Lobatae Radix herb pair. Chinese Traditional and Herbal Drugs. 54(23) (2023) 7853-7861
• [13] Cao T L, Hao J H, Li W D. Optimization of protein extraction and analysis of hypoglycemic activity in vitro of 6 different enzymatic hydrolysates from protein Mulberry leaves. Science and Technology of Food Industry. 44(12) (2023) 232-241
• [14] Jiang H L, Sun Y R, Wei Z Y, et al. Research progress in 4 blood sugar-lowing medicinal materials with edible value. Food Research and Development. 44(8) (2023) 213-217
• [15] Ma Z Y, Ding L, Zhong F Y, et al. Research progress on hypoglycemic action and mechanism of Mulberry leaf. Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology. 25(1) (2023) 156-162
• [16] Deng M. Research progress on application of Pueraria Lobate in food. Jiangsu Condiment and Subsidiary Food. 4 (2023) 1-3
• [17] Jiang X Y, Li W B, Liu Y, et al. The active ingredients of pueraria and its application in food. Journal of Wuhan Polytechnic University. 42(5) (2023) 11-18
• [18] Huang Y D, Cheng J X, Shi Y,et al. Panax notoginseng: a review on chemical components, chromatographic analysis, P. notoginseng extracts, and pharmacology in recent five years. China Journal of Chinese Materia Medica. 47(10) (2022) 2584-2596
• [19] Niu S R, Wang F Z, Cui W Y, et al. Research progress on extraction, separation and purification, antioxidant activity of active components from Panax notoginseng. Journal of Food Safety and Quality. 14(19) (2023)163-171
• [20] Dang Q W. The pharmacological mechanism of Panax Notoginseng multi-pathway regulating inflammation-related chronic diseases. Guangming Journal of Chinese Medicine. 37(20) (2022) 3703-3705

• Document Type: article